Man Faints in Oval Office During White House Announcement
During a Thursday press conference in the Oval Office, a man fainted while President Donald Trump was announcing a deal with drugmakers to reduce obesity drug costs. The incident was captured on video and widely shared online.
Initial Reports and Public Reaction
Independent journalist Eric Daugherty tweeted the video, writing,
“A man just passed out during President Trump’s Oval Office announcement. Oz SPRUNG into action and assisted him.”He also urged people to
“Pray for him.”The live feed was interrupted shortly after the man collapsed, prompting many viewers to express concern and offer prayers for his wellbeing.
Mistaken Identity and Company Clarification
The man was first identified by some as Gordon Findlay, alleged to be a Novo Nordisk executive. A post on X claimed:
“BREAKING: Novo Nordisk executive Gordon Findlay collapses during Trump's announcement in Oval Office, announcement suspended.”
However, Novo Nordisk clarified that the individual was not affiliated with their company. The company stated:
“CEO Mike Doustdar and EVP, US Operations, Dave Moore were the only two Novo Nordisk representatives in the Oval Office. We hope the gentleman who suffered a medical incident today is okay.”
White House Statement
White House Press Secretary Karoline Leavitt confirmed the situation, saying:
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted.”
Summary
The fainting incident in the Oval Office during President Trump's obesity drug cost announcement involved a man mistakenly linked to Novo Nordisk, who was not affiliated with the company according to their statement.
Author's summary: A man fainted during President Trump's Oval Office announcement on obesity drug pricing, initially misidentified as a Novo Nordisk executive, a claim the company denied.